Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.91B |
| 2 |
SPCX
SpaceX
SPCX
|
+$871M |
| 3 |
Eli Lilly
LLY
|
+$719M |
| 4 |
Amazon
AMZN
|
+$698M |
| 5 |
Netflix
NFLX
|
+$627M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$3B |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.54B |
| 3 |
TSMC
TSM
|
+$1.42B |
| 4 |
NVIDIA
NVDA
|
+$1.41B |
| 5 |
SNDK
Sandisk
SNDK
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.67% |
| 2 | Technology | 3.92% |
| 3 | Healthcare | 2.55% |
| 4 | Industrials | 2.24% |
| 5 | Financials | 2.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SMCY
12201
CALL
YieldMax SMCI Option Income Strategy ETF
SMCY
$145M
| $164K | ﹤0.01% |
32,500
-4,800
| -13% | -$29.5K |
|
|
BRAG
12202
CALL
Bragg Gaming Group
BRAG
$42.9M
| $164K | ﹤0.01% |
+95,500
| New | +$175K |
|
12203
CALL
Telos
TLS
$316M
| $164K | ﹤0.01% |
+35,700
| New | +$158K |
|
|
AMRN
12204
CALL
Amarin Corp
AMRN
$294M
| $164K | ﹤0.01% |
10,300
-700
| -6% | -$10.3K |
|
|
FUTG
12205
Leverage Shares 2x Long FUTU Daily ETF
FUTG
$24.3M
| $164K | ﹤0.01% |
+50,705
| New | +$395K |
|
12206
Sono-Tek
SOTK
$70.7M
| $164K | ﹤0.01% |
26,764
+3,101
| +13% | +$15K |
|
|
YSG
12207
Yatsen Holding
YSG
$240M
| $164K | ﹤0.01% |
51,581
-71,874
| -58% | -$217K |
|
12208
PUT
Korro Bio
KRRO
$207M
| $163K | ﹤0.01% |
12,400
-156,300
| -93% | -$1.94M |
|
|
INR
12209
Infinity Natural Resources
INR
$273M
| $163K | ﹤0.01% |
12,857
-149,601
| -92% | -$2.22M |
|
12210
CALL
Pure Cycle
PCYO
$268M
| $163K | ﹤0.01% |
+15,200
| New | +$166K |
|
12211
PUT
NLI Holdings
NL
$343M
| $162K | ﹤0.01% |
+27,300
| New | +$168K |
|
12212
AngioDynamics
ANGO
$648M
| $162K | ﹤0.01% |
12,484
-35,838
| -74% | -$408K |
|
|
PHAR
12213
Pharming Group
PHAR
$747M
| $162K | ﹤0.01% |
11,972
+1,783
| +17% | +$25.8K |
|
12214
PUT
Inseego
INSG
$68M
| $162K | ﹤0.01% |
15,700
-44,400
| -74% | -$595K |
|
12215
PUT
Coherus Oncology
CHRS
$205M
| $162K | ﹤0.01% |
115,800
-5,200
| -4% | -$8.49K |
|
|
MWYN
12216
Marwynn Holdings
MWYN
$19M
| $162K | ﹤0.01% |
152,878
+137,112
| +870% | +$113K |
|
12217
PUT
Fathom Holdings
FTHM
$18.5M
| $162K | ﹤0.01% |
160,300
| – | – |
|
12218
CALL
Compass Therapeutics
CMPX
$333M
| $162K | ﹤0.01% |
73,800
-400
| -0.5% | -$1.18K |
|
12219
CALL
Upexi
UPXI
$75.7M
| $161K | ﹤0.01% |
205,700
-60,600
| -23% | -$70.4K |
|
|
OGG
12220
PUT
Osisko Gold Group
OGG
$847M
| $161K | ﹤0.01% |
+65,500
| New | +$194K |
|
12221
Rafael Holdings
RFL
$111M
| $161K | ﹤0.01% |
49,122
+38,541
| +364% | +$61.9K |
|
12222
PUT
Blink Charging
BLNK
$75.4M
| $161K | ﹤0.01% |
251,600
+193,500
| +333% | +$140K |
|
12223
PUT
4D Molecular Therapeutics
FDMT
$753M
| $161K | ﹤0.01% |
12,100
-11,600
| -49% | -$113K |
|
|
MREO
12224
CALL
Mereo BioPharma
MREO
$45.5M
| $160K | ﹤0.01% |
504,900
+117,900
| +30% | +$35.4K |
|
12225
PUT
Lakeland Industries
LAKE
$104M
| $160K | ﹤0.01% |
15,000
+1,300
| +9% | +$13.1K |
|
Similar funds
Citadel Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Citadel Advisors held 15,445 positions worth $875B, up 41% from $618B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q2 2026 filing shows 2,573 new, 6,088 increased, 4,803 reduced and 1,873 closed positions. Its largest new stake was SpaceX: 5,129,884 shares worth $876M. The largest sale was Micron Technology, an estimated $3B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 79% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q2 2026 buy was SpaceX: 5,129,884 shares worth $876M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.91B increase.
- Citadel Advisors's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $3B.
- Citadel Advisors fully exited iShares 7-10 Year Treasury Bond ETF in Q2 2026, selling an estimated $325M.
- Citadel Advisors's ten largest holdings make up 23% of its $875B portfolio in Q2 2026.
- Citadel Advisors opened 2,573 new positions and closed 1,873 in Q2 2026.
- Citadel Advisors's portfolio value rose 41% quarter-over-quarter to $875B.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.